We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$976M
AUM Growth
+$257M
Cap. Flow
+$279M
Cap. Flow %
28.55%
Top 10 Hldgs %
76.43%
Holding
234
New
114
Increased
26
Reduced
16
Closed
77

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$370M
2
AIG icon
American International
AIG
+$8.49M
3
AMP icon
Ameriprise Financial
AMP
+$7.55M
4
TROW icon
T. Rowe Price
TROW
+$7.55M
5
V icon
Visa
V
+$6.43M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$85.7M
2
FNB icon
FNB Corp
FNB
+$8.22M
3
TRV icon
Travelers Companies
TRV
+$7.78M
4
SHW icon
Sherwin-Williams
SHW
+$7.34M
5
WTW icon
Willis Towers Watson
WTW
+$7.28M

Sector Composition

Rank Sector Weight
1 Healthcare 37.59%
2 Financials 12.34%
3 Technology 4.43%
4 Industrials 4.41%
5 Consumer Discretionary 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$133B
$3.2M 0.33%
52,289
+11,889
+29% +$744K
ARDX icon
27
Ardelyx
ARDX
$1.22B
$3.04M 0.31%
461,162
+320,096
+227% +$1.9M
SSNC icon
28
SS&C Technologies
SSNC
$18.6B
$3.01M 0.31%
74,382
+57,631
+344% +$2.35M
AMTD
29
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.98M 0.31%
+58,265
New +$2.91M
MCHP icon
30
Microchip Technology
MCHP
$40.3B
$2.88M 0.3%
+65,600
New +$2.97M
ENOV icon
31
Enovis
ENOV
$1.68B
$2.74M 0.28%
+40,172
New +$2.7M
RXDX
32
DELISTED
Ignyta, Inc.
RXDX
$2.67M 0.27%
100,082
-33,502
-25% -$544K
GNRC icon
33
Generac Holdings
GNRC
$11.6B
$2.65M 0.27%
+53,504
New +$2.66M
CRM icon
34
Salesforce
CRM
$151B
$2.54M 0.26%
24,800
+816
+3% +$83.2K
RDUS
35
DELISTED
Radius Health, Inc.
RDUS
$2.18M 0.22%
+68,647
New +$2.15M
INSM icon
36
Insmed
INSM
$21.4B
$2.15M 0.22%
68,856
+3,437
+5% +$102K
HRTX icon
37
Heron Therapeutics
HRTX
$93.9M
$2.1M 0.22%
116,290
+76,212
+190% +$1.24M
RCI icon
38
Rogers Communications
RCI
$18.3B
$2.06M 0.21%
+40,450
New +$2.11M
KDMN
39
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.03M 0.21%
561,040
-39,188
-7% -$140K
BHF icon
40
Brighthouse Financial
BHF
$3.56B
$1.99M 0.2%
33,891
+17,866
+111% +$1.06M
EXPO icon
41
Exponent
EXPO
$3.24B
$1.98M 0.2%
+55,680
New +$2.04M
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.95M 0.2%
68,906
+8,442
+14% +$236K
AXS icon
43
AXIS Capital
AXS
$7.68B
$1.92M 0.2%
38,111
+25,843
+211% +$1.38M
ADI icon
44
Analog Devices
ADI
$179B
$1.87M 0.19%
+21,000
New +$1.86M
CP icon
45
Canadian Pacific Kansas City
CP
$78.1B
$1.83M 0.19%
+50,000
New +$1.74M
FOLD
46
DELISTED
Amicus Therapeutics
FOLD
$1.77M 0.18%
123,222
+70,377
+133% +$967K
MTX icon
47
Minerals Technologies
MTX
$2.36B
$1.76M 0.18%
+25,578
New +$1.82M
LOW icon
48
Lowe's Companies
LOW
$117B
$1.74M 0.18%
+18,680
New +$1.54M
ACM icon
49
Aecom
ACM
$9.3B
$1.63M 0.17%
+43,873
New +$1.6M
BT
50
DELISTED
BT Group plc (ADR)
BT
$1.62M 0.17%
+89,000
New +$1.57M
1
2
3 4 5

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q4 2017 Portfolio in Review

As of Q4 2017, Crestline Management held 234 positions worth $976M, up 36% from $719M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Crestline Management deployed $279M of net new capital in Q4 2017, opening 114 new positions and adding to 26 existing holdings. Its largest new stake was Denali Therapeutics: 20,574,298 shares worth $322M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 5.7% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Juno Therapeutics, Inc., an estimated $85.7M trimmed.

  • Crestline Management's largest Q4 2017 buy was Denali Therapeutics: 20,574,298 shares worth $322M.
  • Crestline Management added most to Ameriprise Financial in Q4 2017, an estimated $7.55M increase.
  • Crestline Management's biggest Q4 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $85.7M.
  • Crestline Management fully exited FNB Corp in Q4 2017, selling an estimated $8.22M.
  • Crestline Management's ten largest holdings make up 76% of its $976M portfolio in Q4 2017.
  • Crestline Management opened 114 new positions and closed 77 in Q4 2017.
  • Crestline Management's portfolio value rose 36% quarter-over-quarter to $976M.

Based on Crestline Management's 13F filing for Q4 2017, filed 14 Feb 2018.